What kind of people are "engines"? Studies show that they are more likely to be psychopaths, sadists, and narcissists.

Published Date: 17 Feb 2023

Online dating has revolutionized dating by creating more opportunities to meet partners than ever before.

Read Full News

Latest News

Single Dose of MM120 (LSD) Shows Lasting Anxiety Reduction in GAD: Phase 2b Results Chelsie Derman

A phase 2b trial finds a single 100 μg dose of MM120 reduced GAD symptoms with benefits lasting 12 weeks, highlighting the promise of psychedelic therapy.

FDA Releases CRL Detailing Safety Concerns for MDMA-Assisted Therapy in PTSD Chelsie Derman

MDMA’s CRL, now available to the public, cites gaps in safety data, selection bias, and limited durability.

Prenatal Opioid Pain Medications Likely Not Linked to Autism or ADHD Risk Chelsie Derman

A study suggests associations between opioids during pregnancy and neurodevelopmental disorders are mainly due to confounding factors, not causal effects.

Atopic Eczema Linked to Suicidal Ideation in Global Study of 30,000 Adults Chelsie Derman

EADV 2025 findings show patients with atopic eczema face greater risks of depression, anxiety, sleep disorders, and stigmatization.

FDA Initiates Acetaminophen Label Change, Leucovorin Approval for Cerebral Folate Deficiency Abigail Brooks, MA

The Agency initiated an acetaminophen label change to reflect evidence of potential harms in pregnant women and an approval of leucovorin for CFD.

Daily Ammoxetine at 40, 60 mg Outperforms Placebo for MDD in Phase 2 Trial Chelsie Derman

A phase 2 trial demonstrated the effectiveness, safety, and tolerability of ammoxetine (40 and 60 mg) in patients with major depressive disorder.

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Latest News

A phase 2b trial finds a single 100 μg dose of MM120 reduced GAD symptoms with benefits lasting 12 weeks, highlighting the promise of psychedelic therapy.

MDMA’s CRL, now available to the public, cites gaps in safety data, selection bias, and limited durability.

A study suggests associations between opioids during pregnancy and neurodevelopmental disorders are mainly due to confounding factors, not causal effects.

EADV 2025 findings show patients with atopic eczema face greater risks of depression, anxiety, sleep disorders, and stigmatization.

The Agency initiated an acetaminophen label change to reflect evidence of potential harms in pregnant women and an approval of leucovorin for CFD.

A phase 2 trial demonstrated the effectiveness, safety, and tolerability of ammoxetine (40 and 60 mg) in patients with major depressive disorder.

News All Time

Antidepressants Differ Significantly in Cardiometabolic Side Effects Chelsie Derman

A large analysis reveals clinically relevant differences in weight, blood pressure, and heart rate across 30 antidepressants.

Repetitive TMS Boosts Quality of Life in Younger, Older Adults with Depression Chelsie Derman

Study finds repetitive transcranial magnetic stimulation brings clinically meaningful improvements in quality of life for adults with MDD through 12 weeks.

Non-Invasive Vagus Nerve Stimulation Boosts Food Liking in Depression Chelsie Derman

Right transcutaneous auricular VNS (taVNS) acutely increases food liking in patients with MDD, especially those with high anhedonia, a study found.

Rethinking Addiction Recovery: From Symptoms to Systems

Rethinking Addiction Recovery: From Symptoms to Systems

Comorbid Anxiety Lowers Accelerated Theta Burst Response in Depression Chelsie Derman

A study finds older adults with depression and comorbid anxiety show less improvement after accelerated theta burst stimulation.

Stigma Around Alcohol-Related Liver Disease Poses Major Barrier to Care

Stigma Around Alcohol-Related Liver Disease Poses Major Barrier to Care

6 Psychiatry Headlines You Missed in October 2025

6 Psychiatry Headlines You Missed in October 2025

Women Face Higher Risk of Advanced Fibrosis Due to Binge Drinking Than Men

Women Face Higher Risk of Advanced Fibrosis Due to Binge Drinking Than Men

Psychedelics might help terminal patients find peace

In clinical trials around the world, a surprising treatment is showing promise for people with terminal illnesses: psychedelic therapy.

Tracing schizophrenia's origins: Study maps chromatin accessibility in postmortem brain tissue

Schizophrenia is a severe neuropsychiatric disorder characterized by hallucinations, false beliefs about oneself or the world (i.e., delusions), and other disruptions in thought, emotion and perception. Recent genetic studies ...

Not all PTSD therapies keep veterans in treatment, study warns

About a quarter of U.S. service members and veterans who start psychotherapy for post-traumatic stress disorder quit before they finish treatment. But not all therapies are equal in their appeal, with some effective approaches ...

Inequalities in mental health compulsory admissions worsened during the pandemic, UK study finds

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and South London and Maudsley NHS Foundation Trust has shown striking inequalities between ethnic groups in the rate of involuntary admissions ...

Childhood experiences may hold the key to adult relationship patterns

In the field of psychology, attachment theory proposes that interpersonal experiences early in life should shape how people think, feel and behave in their close relationships in adulthood.

An 'invisible disaster': Aliso Canyon gas blowout is affecting residents' long-term mental health

A decade after the largest methane leak in U.S. history, a new study by UCLA and NYU researchers sheds light on the mental health impacts of the 2015–2016 Aliso Canyon natural gas disaster on residents of Porter Ranch and ...

Inventory assesses the risky choices of modern life

Quitting a job. Buying a house. Everyone at some point in their lives will make a risky choice that may have a cascading effect on their life path. However, with increasing globalization and technological advancements, choices ...

Incarcerated people in U.S. prison express important perceptions of staff

A new study conducted in a U.S. prison suggests that incarcerated men have complex perceptions of staff that stem from previous communications and interactions.

Recommended News For You

Traveling to Die: The Latest Form of Medical Tourism

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

What Role Should Genomic Classifier Testing Play in Prostate Cancer?

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

The American College of Physicians updated its recommendations for colorectal cancer screening.

Recommended Articles For You

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy 

The Mysterious World of Petechiae: Exploring Causes and Treatments 

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options 

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Discovery of cellular identity may influence cancer treatment

2.

What is Mohs micrographic surgery? 8 FAQs about Mohs

3.

Breast cancer screening in women's 40s can save lives, study says

4.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

5.

Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.

1.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

2.

The Cutting-Edge of Phlebectomy: Redefining Vein Care

3.

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

4.

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction 

5.

Understanding Mantle Cell Lymphoma Prognosis.

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

2.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot